VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 8, 2011) -

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), developer and marketer of proprietary technologies for the production of organic-based, high-value agricultural products from organic wastes, is pleased to announce the appointment of S.R. Prabhu as Chief Technical Officer of the company.

Prabhu has been employed with TerraBioGen as its' Senior Research Scientist/Research Manager for the past 8 years and has been the key individual in developing value in the Company's proprietary EATAD process and resulting soil fertility products. After completing graduate studies in Agricultural Microbiology from Tamil Nadu Agricultural University, India, Prabhu served the Agricultural Research Service (ARS) of the Indian Council of Agricultural Research for over a decade before joining TerraBioGen. To his credit, Prabhu has many widely adopted bio-resource technologies within the agricultural community. His primary responsibility with TerraBioGen includes the on-going optimization of the TerraBioGen EATAD process and the further development of innovative biological soil fertility products.

Blair Heffelfinger, President and CEO of the company stated that "this appointment reflects the important contributions Prabhu has been making for the company. As our biological research department continues to expand in the area of agricultural bioscience, Prabhu's role will continue to grow."

About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology and the quality of its agricultural products. It is further committed to developing a world wide marketing capability to ensure market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Contact Information: TerraBioGen Technologies Inc.
Blair Heffelfinger
President & CEO
(604) 924-1023 ext 316
(604) 924-1043 (FAX)
bheffelfinger@terrabiogen.com
or
TerraBioGen Technologies Inc.
Bob Nowell
CFO & Corporate Secretary
(604) 924-1023 ext 306
(604) 924-1043 (FAX)
bnowell@terrabiogen.com